David Peace

Toxicity and therapeutic efficacy of high-dose interleukin 2. In vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemia

D. Peace, M. Cheever, David Peace, 1989, The Journal of experimental medicine.

IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.

P. Greenberg, D. Peace, M. Cheever, 1988, Journal of immunology.

CD4+ T-cell immunity to mutated ras protein in pancreatic and colon cancer patients.

D. Byrd, R. Fenton, L. McCahill, 1995, Cancer research.

Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory.

J. Thompson, L. Matis, P. Greenberg, 1987, Journal of immunology.